Millen, Brian A.

A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia

Kinon, B. J., Zhang, L., Millen, B. A., Osuntokun, O. O., Williams, J. E., Kollack-Walker, S., Jackson, K., Kryzhanovskaya, L., & Jarkova, N. (2011) · Journal of Clinical Psychopharmacology

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 256

Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2/3 receptor agonist pomaglumetad methionil in schizophrenia

Kinon, B. J., Millen, B. A., Zhang, L., & McKinzie, D. L. (2015) · Biological Psychiatry

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 169

Development of gatekeeping strategies in confirmatory clinical trials

Dmitrienko, A., Millen, B. A., Brechenmacher, T., & Paux, G. (2011) · Biometrical Journal

Statistical Methods in Clinical TrialsStatistical Methods and Bayesian Inference

Cited by 43